2.91 USD
↗ 0.26 (9.81%)AT CLOSE (03:59 PM EDT)
Atossa Therapeutics, Inc. Common Stock
ATOSNASDAQ • USD
3.01
↗ 0.10 (3.27%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
3.01
↗ 0.10 (3.27%)
Market: CLOSED
ATOS is currently priced at $2.91. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Oct 16, 2026.
Open?$2.59
High?$2.95
Low?$2.51
Prev. Close?$2.65
Volume?104.6K
Avg. Volume?81.9K
VWAP?$2.75
Rel. Volume?1.28x
Bid / Ask
Bid?$2.98 × 100
Ask?$3.09 × 100
Spread?$0.11
Midpoint?$3.04
Valuation & Ratios
Market Cap?29.0M
Shares Out?10.0M
Float?8.9M
Float %?89.2%
P/E Ratio?N/A
P/B Ratio?1.08
EPS?-$3.78
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
Themes
Employees
14
Market Cap
29.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2012-11-08
Address
1448 NW MARKET STREET
SEATTLE, WA 98107
Phone: 206.588.0256
SEATTLE, WA 98107
Phone: 206.588.0256
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?28
Piotroski F-Score?0/9Weak
Altman Z-Score?-11.34Distress
Confidence?54%Low
Short InterestVery High
Short % of Float?8.86%Elevated
Short Interest?788.3K
Days to Cover?11.3
Free Float8.9M
Avg Daily Volume69.7K
Settlement Date2026-09-30
Financial Health
Current Ratio?5.69Strong
Quick Ratio?5.14Strong
Cash Ratio?4.79Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.08CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-140.6%WEAK▾
S&P3
ROA?-116.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-35783000
Enterprise Value?$2.9M
Fundamentals ratios updated end of day